GlassScriptPhysician profile
Ameesh Parikh
NPI 1699876698
$4,963.31
in general payments reported to CMS, 2019-2025
28 companies · $708 in 2025
The $708 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $175 · 2021: $253 · 2022: $979 · 2023: $744 · 2024: $1,605 · 2025: $708.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,056.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $616.71 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.87 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $440.75 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $407.96 | 2019-2024 | Eliquis, Camzyos |
| Amgen INC. | $393.31 | 2019-2025 | Repatha, Repatha |
| Abiomed | $338.34 | 2024-2025 | Impella |
| Abbott Laboratories | $330.94 | 2021-2024 | Mitraclip |
| Sanofi-Aventis U.S. LLC | $312.76 | 2019-2024 | |
| Shockwave Medical, INC | $295.93 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.66 | 2019-2025 | Lifevest |
| Medtronic, INC. | $139.41 | 2022-2024 | Linq II |
| Merck Sharp & Dohme LLC | $134.70 | 2021-2024 | Verquvo |
| Medtronic Vascular, INC. | $133.97 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $112.15 | 2022-2025 | Wainua |
| Janssen Pharmaceuticals, INC | $88.81 | 2019-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $66.34 | 2023-2024 | Assure Wcd |
| Boston Scientific Corporation | $59.16 | 2023 | Watchman Access System |
| Baxter Healthcare | $44.74 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $44.32 | 2025 | |
| Impulse Dynamics (USA) INC. | $43.62 | 2022-2023 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $33.20 | 2025 | Evkeeza |
| Amarin Pharma, INC. | $31.33 | 2019-2020 | |
| Bardy Diagnostics, INC. | $27.66 | 2022 | |
| Chiesi USA, INC. | $25.40 | 2020 | |
| Alnylam Pharmaceuticals INC. | $20.99 | 2022 | |
| Philips North America LLC | $18.15 | 2024 | (Am5) Lead Management |
| Edwards Lifesciences Corporation | $15.03 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $13.10 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ameesh Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.